http://www.healthcare-alerts.comhttps://www.healthcare-alerts.com/breaking-news/breaking-news2 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=20707 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=20707 TEST tmpl_var form_bodyText Thu, 02 Jan 2014 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=20712 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=20712 TEST tmpl_var form_bodyText Tue, 31 Dec 2013 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19341 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19341 There were a million arguments against healthcare reform a year ago. One was that if President Obama got his way and expanded health insurance to Mon, 21 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19342 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19342 Doxo’s bid to wipe out paper business correspondence attracted a $10 million round of venture financing last month, outpacing several others as the biggest single Mon, 21 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19337 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19337 Alnylam Pharmaceuticals CEO John Maraganore found out his firm was getting sued by one of its business partners for more than $1 billion when an Fri, 18 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19322 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19322 This week’s big headlines came from a couple of personnel moves, and one potentially nasty trade secrets lawsuit. —Dendreon (NASDAQ: DNDN) said that David Urdal, Thu, 17 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19333 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19333 Over the next week, a large number of progressive groups, health care advocacy organizations and high-profile administration officials and congressional lawmakers will hit the road Thu, 17 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19334 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19334 The devastation caused by the earthquake and tsunami in Japan apparently isn’t halting the biotech wheels of commerce between Asia and the Bay Area, though Thu, 17 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19321 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19321 Tekmira Pharmaceuticals, the Vancouver, BC-based maker of technology to deliver RNA interference therapies, has filed a lawsuit against Cambridge, MA-based Alnylam Pharmaceuticals seeking damages of Wed, 16 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19327 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19327 Medicare officials signaled Wednesday that they will not change a payment policy for biotech drugs made by Amgen and Johnson & Johnson when they are Wed, 16 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19307 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19307 The San Francisco Bay Area has a storied tradition as the birthplace and leading hub of biotechnology, but something curious has happened the past couple Mon, 14 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19308 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19308 Developers of a biomass project in Washington state have dropped plans for the 55-megawatt plant that would have generated electricity from wood waste. ADAGE spokesman Mon, 14 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19310 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19310 The one-year anniversary of the healthcare reform law is fast approaching, giving both supporters and critics a high-profile opportunity to debate the impact of the Mon, 14 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19312 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19312 An increasing number of hospitals — along with health plans — are posting the prices of common medical procedures and tests on their websites. What’s Mon, 14 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19328 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19328 A top immunologist and 42 researchers are leaving the Institute for Systems Biology (ISB) to join another biotechnology nonprofit, Seattle BioMed. Alan Aderem, who co-founded Mon, 14 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19299 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19299 David Urdal, the scientific entrepreneur who co-founded the modern version of Dendreon over 15 years ago and helped turn it into a pioneer of cancer Fri, 11 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19304 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19304 Big U.S. and Japanese drug makers said they're still trying to account for all of their employees in Japan in the wake of Friday's earthquake Fri, 11 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19300 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19300 Seattle-based Dendreon (NASDAQ: DNDN) said today it has won FDA clearance to quadruple the output from the New Jersey factory where it makes its lone Thu, 10 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19301 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19301 One of our local billionaires made a couple of significant biotech investments this week, while one of the venerable names from the biotech scene faded Thu, 10 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19282 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19282 Targeted Genetics has been a shell of its former self for a couple years now, but today it’s officially no longer the same old Targeted Wed, 09 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19283 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19283 Calypso Medical Technologies, on the surface, looked like it was on the brink of breakout success in September 2009. The Seattle-based company raised $50 million Wed, 09 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19285 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19285 Medtronic Inc., the world's largest medical device company, said Wednesday it has resolved two warning letters from the Food and Drug Administration over lax oversight Wed, 09 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19284 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19284 Global health innovators have a rich new venture capitalist to turn to—the Bill & Melinda Gates Foundation. The Seattle-based nonprofit, the world’s largest philanthropy with Tue, 08 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19297 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19297 Liquidia Technologies is getting a $10 million boost from the Bill & Melinda Gates Foundation to support its work on next-gen vaccines. Only this time Tue, 08 Mar 2011 12:00:00 GMT https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19272 https://www.healthcare-alerts.com/breaking-news/breaking-news2?func=viewAbstract&abstractId=19272 When a company like Plexxikon can’t pull off a big-time IPO, you know something’s out of whack in the biotech world. Berkeley, CA-based Plexxikon hit Mon, 07 Mar 2011 12:00:00 GMT